Display options
Share it on

Case Rep Infect Dis. 2015;2015:630816. doi: 10.1155/2015/630816. Epub 2015 Nov 04.

First Report of Ventriculoperitoneal Shunt Infection due to Cyberlindnera fabianii.

Case reports in infectious diseases

Jonathan Baghdadi, Peera Hemarajata, Romney Humphries, Theodoros Kelesidis

Affiliations

  1. Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
  2. Department of Pathology & Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

PMID: 26618013 PMCID: PMC4649088 DOI: 10.1155/2015/630816

Abstract

Fungal infections in the central nervous system (CNS) are associated with significant morbidity and death. Transient fungemia in immunocompetent patients without any other risk factors for fungemia has been suggested as a possible mechanism that may lead to serious fungal ventriculoperitoneal (VP) shunt infections, but evidence is lacking. The clinical spectrum, diagnosis, and optimal therapy of Cyberlindnera fabianii infections remain to be determined. We describe the first case of CNS infection due to C. fabianii that occurred in an immunocompetent adult with a VP shunt. Spontaneous translocation with yeast that is not part of the normal gastrointestinal flora in the setting of ingestion of multiple servings of a fermentation product was the likely source from which Cyberlindnera fabianii gained entrance into the VP shunt system, causing meningitis in this patient. The authors conclude that, in view of the high morbidity associated with yeast infection of the CNS, long-term antifungal therapy should be strongly considered in cases where the VP shunt cannot be completely removed. Transient fungemia may lead to invasive disease in an immunocompetent host with VP shunt, even in the absence of any other risk factors for fungemia and even after remote placement of the VP shunt.

References

  1. J Med Microbiol. 2013 Jun;62(Pt 6):922-5 - PubMed
  2. Clin Infect Dis. 1995 Aug;21(2):323-7 - PubMed
  3. Mycopathologia. 2013 Oct;176(3-4):273-7 - PubMed
  4. J Clin Microbiol. 2006 Mar;44(3):693-9 - PubMed
  5. Diagn Microbiol Infect Dis. 1994 Sep;20(1):33-40 - PubMed
  6. Clin Microbiol Rev. 2004 Apr;17(2):255-67 - PubMed
  7. J Clin Neurosci. 2014 Nov;21(11):2020-1 - PubMed
  8. FEMS Yeast Res. 2008 Sep;8(6):939-54 - PubMed
  9. BMC Res Notes. 2013 Mar 04;6:77 - PubMed
  10. J Clin Microbiol. 2014 Apr;52(4):1253-5 - PubMed
  11. Pediatr Infect Dis J. 2010 Feb;29(2):191 - PubMed
  12. Acta Neurochir (Wien). 2011 Jun;153(6):1347-50 - PubMed
  13. J Med Microbiol. 1972 Feb;5(1):21-30 - PubMed
  14. HIV Med. 2010 Apr;11(4):276-81 - PubMed
  15. Genome Announc. 2014 Aug 07;2(4):null - PubMed
  16. Med Mycol. 2008 Sep;46(6):601-5 - PubMed
  17. J Pediatr Neurosci. 2009 Jul;4(2):73-5 - PubMed
  18. J Clin Microbiol. 2010 May;48(5):1924-5 - PubMed
  19. Clin Infect Dis. 2005 Jun 1;40(11):1625-34 - PubMed
  20. Int J Food Microbiol. 2013 Sep 16;166(3):426-32 - PubMed
  21. Mycoses. 2006 Jul;49(4):331-4 - PubMed
  22. Med Mycol. 2012 Apr;50(3):310-4 - PubMed
  23. Pediatr Neurosci. 1989;15(3):125-30 - PubMed
  24. MMWR Recomm Rep. 2009 Sep 4;58(RR-11):1-166 - PubMed
  25. J Infect Dis. 1990 May;161(5):1040-1 - PubMed
  26. Med Mycol. 2006 Mar;44(2):185-7 - PubMed
  27. Int J Food Microbiol. 2008 May 31;124(2):115-25 - PubMed
  28. Clin Infect Dis. 2009 Mar 1;48(5):503-35 - PubMed

Publication Types

Grant support